Tuttle Capital Management LLC Invests $240,000 in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Tuttle Capital Management LLC bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIGet Rating) during the 1st quarter, Holdings Channel reports. The firm bought 2,667 shares of the exchange traded fund’s stock, valued at approximately $240,000.

Other large investors also recently made changes to their positions in the company. Axiom Investment Management LLC bought a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth $25,000. Norwood Financial Corp grew its holdings in shares of SPDR S&P Biotech ETF by 292.9% during the first quarter. Norwood Financial Corp now owns 275 shares of the exchange traded fund’s stock worth $25,000 after purchasing an additional 205 shares during the last quarter. Integrity Financial Corp WA bought a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth $29,000. Concorde Financial Corp bought a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth $33,000. Finally, Joseph P. Lucia & Associates LLC bought a new stake in shares of SPDR S&P Biotech ETF during the first quarter worth $40,000.

SPDR S&P Biotech ETF Trading Down 2.0 %

SPDR S&P Biotech ETF stock opened at $79.47 on Tuesday. The business’s 50-day simple moving average is $74.91 and its 200 day simple moving average is $82.09. SPDR S&P Biotech ETF has a 12-month low of $61.78 and a 12-month high of $136.61.

About SPDR S&P Biotech ETF

(Get Rating)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Stories

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIGet Rating).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.